An HRT expert discusses observational data showing brain stabilization and increased energy in women using hormone therapy, then announces a new clinical trial testing a brain-targeted SERM with brain imaging, cognitive tests, and blood biomarkers to measure effects while avoiding reproductive cancer risk.
If you look at observational data, like women who spontaneously decide to take hormones as compared to those who decide not to take hormones, the differences are quite subtle, but there seems to be a little bit of a stabilization or higher brain energy levels in the women on hormone therapy. We just launched a clinical trial where we do brain scans and cognitive testing and blood biomarkers, and we do very thorough evaluations. Before and during treatment. We're doing a specific type of hormone therapy, which is more like a nutraceutical. It's a select estrogen receptor modulator, and it's selective in that it specifically goes into your brain to support brain energy while having either neutral or inhibitory effects on the reproductive system, which means it does not increase the risk of reproductive cancers.
